Posted by
What to know about deep sleep

What to know about deep sleep

Slow wave sleep, also called deep sleep, is an important stage in the sleep cycle that enables proper brain function and memory. While most adults are aware that they should aim for between 7 and 9 hours of sleep each night, the science of sleep is quite complex. The two main categories of sleep are […]

Posted by
FDA Takes Hard Look at CBD

FDA Takes Hard Look at CBD

By Dennis ThompsonHealthDay Reporter Latest Neurology News FRIDAY, May 31, 2019 (HealthDay News) — The U.S. Food and Drug Administration took a good look at the safety and effectiveness of CBD products on Friday, as it weighs how to best regulate the hemp-derived compound going forward. During a public hearing that stretched for hours, the […]

Posted by
Why do people laugh in their sleep?

Why do people laugh in their sleep?

Laughing during sleep, or hypnogely, is relatively common and is not usually anything to worry about. In most cases, researchers believe that the cause is laughing at a dream during rapid eye movement sleep, which is entirely harmless. In some cases, sleep laughing has links to sleep disorders. In rare cases, hypnogely can be a […]

Posted by
What are the side effects and risks of Ritalin?

What are the side effects and risks of Ritalin?

Doctors often prescribe Ritalin for the treatment of ADHD and sometimes for narcolepsy. Ritalin can cause various side effects and also has the potential for misuse and addiction. Ritalin is the brand name for methylphenidate, a medication that stimulates the production of dopamine and norepinephrine in the brain. Experts believe that these two chemicals play […]

Posted by
What to know about neuralgia

What to know about neuralgia

Neuralgia refers to severe, shooting pain that occurs due to a damaged or irritated nerve. Neuralgia can affect any part of the body, causing mild to severe pain. Certain medications and surgical procedures can effectively treat neuralgia. Severe neuralgia can interfere with a person’s ability to perform everyday tasks and may impact their quality of […]

Posted by
Early-onset Alzheimer’s: Is ‘bad cholesterol’ a factor?

Early-onset Alzheimer’s: Is ‘bad cholesterol’ a factor?

Millions of people live with Alzheimer’s disease, a condition that affects memory and thinking skills. While most people develop it later in life, some have early-onset Alzheimer’s, which sets in before the age of 65 years. Its causes and risk factors are unclear, but scientists wonder if “bad cholesterol” plays a role. ‘Bad’ cholesterol may […]

Posted by
A Less Invasive Fix Works Well for Abdominal Aneurysm

A Less Invasive Fix Works Well for Abdominal Aneurysm

By Serena GordonHealthDay Reporter Latest Neurology News THURSDAY, May 30, 2019 (HealthDay News) — Bulges (aneurysms) in the abdominal aorta can pose real danger, but research suggests a less invasive method may be as good a fix for the problem as traditional surgery. The less invasive procedure is called endovascular repair. There are a number […]

Posted by
Some CBD Oils, Marijuana-Derived Drug Now Allowed on Flights: TSA

Some CBD Oils, Marijuana-Derived Drug Now Allowed on Flights: TSA

WEDNESDAY, May 29, 2019 (HealthDay News) — Airline passengers will now be allowed to travel with some forms of CBD oil and an epilepsy drug derived from marijuana, the U.S. Transportation Security Administration says. Latest Neurology News Previously, all forms of marijuana were prohibited in carry-on bags and checked luggage, the Associated Press reported. The […]

Posted by
Scientists discover anti-aging potential in old drug

Scientists discover anti-aging potential in old drug

Clinical trials are underway to test whether rapamycin, a drug that has served as an immune suppressor for decades, could also treat cancer and neurodegeneration. Scientists are also interested in exploring its anti-aging properties. Scientists may have found anti-aging and neuroprotective benefits in an existing immunosuppressant drug. Rapamycin gets its name from Rapa Nui, the […]

Posted by
FDA Approves First Gene Therapy for Spinal Muscular Atrophy

FDA Approves First Gene Therapy for Spinal Muscular Atrophy

Latest Neurology News TUESDAY, May 28, 2019 (HealthDay News) — The first gene therapy has been approved to treat children younger than 2 years with spinal muscular atrophy (SMA), the U.S. Food and Drug Administration announced Friday. Zolgensma (onasemnogene abeparvovec-xioi), an adeno-associated virus vector-based gene therapy, targets the cause of SMA by delivering a fully […]